000			02129 a2200613 4500
005			20250517074048.0
264		0	_c20161114
008			201611s 0 0 eng d
022			_a1476-5578
024	7		_a10.1038/mp.2015.211 _2doi
040			_aNLM _beng _cNLM
100	1		_aHarraz, M M
245	0	0	_aAntidepressant action of ketamine via mTOR is mediated by inhibition of nitrergic Rheb degradation. _h[electronic resource]
260			_bMolecular psychiatry _cMar 2016
300			_a313-9 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650	0	4	_aAnimals
650	0	4	_aAntidepressive Agents _xpharmacology
650	0	4	_aCells, Cultured
650	0	4	_aCerebral Cortex _xcytology
650	0	4	_aCysteine _xanalogs & derivatives
650	0	4	_aDepression _xdrug therapy
650	0	4	_aDisease Models, Animal
650	0	4	_aEmbryo, Mammalian
650	0	4	_aExploratory Behavior _xdrug effects
650	0	4	_aFemale
650	0	4	_aGene Expression Regulation _xdrug effects
650	0	4	_aHEK293 Cells
650	0	4	_aHumans
650	0	4	_aKetamine _xpharmacology
650	0	4	_aMale
650	0	4	_aMice, Inbred C57BL
650	0	4	_aMice, Knockout
650	0	4	_aMonomeric GTP-Binding Proteins _xgenetics
650	0	4	_aN-Methylaspartate _xpharmacology
650	0	4	_aNeurons _xdrug effects
650	0	4	_aNeuropeptides _xgenetics
650	0	4	_aNitric Oxide _xgenetics
650	0	4	_aNitric Oxide Synthase Type I _xdeficiency
650	0	4	_aNitric Oxide Synthase Type II _xdeficiency
650	0	4	_aPregnancy
650	0	4	_aProteolysis _xdrug effects
650	0	4	_aRas Homolog Enriched in Brain Protein
650	0	4	_aS-Nitrosothiols _xpharmacology
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aSwimming _xpsychology
650	0	4	_aTOR Serine-Threonine Kinases _xgenetics
650	0	4	_aTime Factors
700	1		_aTyagi, R
700	1		_aCortés, P
700	1		_aSnyder, S H
773	0		_tMolecular psychiatry _gvol. 21 _gno. 3 _gp. 313-9
856	4	0	_uhttps://doi.org/10.1038/mp.2015.211 _zAvailable from publisher's website
999			_c25644000 _d25644000